InvestorsHub Logo

aCryptoKing

03/16/20 10:53 AM

#15 RE: ValueInvestor15 #11

Nice call: Stock went to $196.36 days after your post! Looks like this market-wide pullback is indiscriminate across ALL stocks; & puts the current price of LH well BELOW that value by OVER $50.00. Some analysts had LH @ a $207.00 price target (& that was BEFORE any of the Coronavirus factored in).

Meanwhile LapCorp has been ALL OVER the NEWS as a KEY part of the Coronavirus Task Force. Is expanding their Walgreens "tuck-in" stores to 600+, developed a COVID-19 test kit (March 5th) its' begun deploying, started 3 8hr shifts to increase test kit production & testing, & is committed to buying back shares as well as making new lab acquisitions this upcoming year (as part of their last public conference call guidance).

Throwing off ~$1B of cash with $11.5B in Gross Revenues BEFORE the Coronavirus business is factored in should provide more capital to execute & accelerate on all their corporate objectives. So, for this company, the Coronavirus, stock decline, continued execution for this growing 50yr old company makes it a stock with LOTS of UPSIDE at these prices.

Added more today: Happily! And leaving some money for one more lucky dip.

aCryptoKing

04/21/20 11:22 AM

#20 RE: ValueInvestor15 #11



NEWS: LabCorp at-home test kit for COVID-19 receives emergency authorization from FDA

BURLINGTON, NC (WBTW) – LabCorp says their at-home test for COVID-19 has received emergency authorization from the U.S. Food and Drug Administration (FDA) and they will prioritize distribution for healthcare workers and first responded.

The company announced Tuesday it has received an Emergency Use Authorization from the FDA, which “permits nasal swab specimens to be collected at home using the Pixel by LabCorp™ COVID-19 test home collection kit if recommended by a healthcare provider after completing a COVID-19 questionnaire.”

“Enabling individuals to self-administer sample collection will help prevent the risk of transmitting the virus to others and reduces the demand for personal protective equipment (PPE) as the tests do not require a clinician to perform the test collection,” LabCorp says.

The kits will “initially be made available to healthcare workers and first responders who may have been exposed to COVID-19 or may be symptomatic.”

The company also said they intend “to make COVID-19 self-collection kits available to consumers in the coming weeks.”

“LabCorp continues to develop new ways to help patients and healthcare providers fight the COVID-19 crisis through our leading testing capabilities and deep scientific and research expertise,” said Adam Schechter, president and CEO of LabCorp. “Our at-home collection kits are designed to make it easier and safer to test healthcare workers and first responders during this important time.”



https://www.newsbreak.com/north-carolina/burlington/news/0OoZKW4S/labcorp-at-home-test-for-covid-19-receives-emergency-authorization-from-fda

LH